These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3017632)

  • 1. Pharmacologic modulation by prostaglandin E1 of superoxide anion production by human polymorphonuclear leukocytes.
    Zimmerman JJ
    Crit Care Med; 1986 Sep; 14(9):761-7. PubMed ID: 3017632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro modulation of human neutrophil superoxide anion generation by various calcium channel antagonists used in ischemia-reperfusion resuscitation.
    Zimmerman JJ; Zuk SM; Millard JR
    Biochem Pharmacol; 1989 Oct; 38(20):3601-10. PubMed ID: 2554927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant use of prostaglandin E1 and prednisolone; inhibition of superoxide anion production by polymorphonuclear leucocytes.
    Miyata M; Ajima H; Kondo Y; Kanno T; Ito M; Nakahata N; Kasukawa R
    Fukushima J Med Sci; 1995 Jun; 41(1):15-28. PubMed ID: 8606039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E and analogs of prostacyclin influencing superoxide production by the human neutrophil NADPH oxidase system.
    Umeki S
    Int J Biochem; 1994 Aug; 26(8):1003-8. PubMed ID: 8088410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E1 inhibits N-formyl-methionyl-leucyl-phenylalanine-mediated depolarization responses by decreasing the proportion of responsive cells without affecting chemotaxin-induced forward light scatter changes.
    Fletcher MP
    J Immunol; 1987 Dec; 139(12):4167-73. PubMed ID: 3693900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E1 attenuates cytotoxic mechanisms of primed neutrophils.
    Tamura DY; Moore EE; Partrick DA; Johnson JL; Offner PJ; Silliman CC
    Shock; 1998 Mar; 9(3):171-6. PubMed ID: 9525323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by reactive aldehydes of superoxide anion radical production from stimulated polymorphonuclear leukocytes and pulmonary alveolar macrophages. Effects on cellular sulfhydryl groups and NADPH oxidase activity.
    Witz G; Lawrie NJ; Amoruso MA; Goldstein BD
    Biochem Pharmacol; 1987 Mar; 36(5):721-6. PubMed ID: 3030333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic inhibition of human polymorphonuclear function by prostaglandin E1 and linsidomine.
    Gladis-Villanueva M; Schrör K
    J Pharm Pharmacol; 1996 Jul; 48(7):706-11. PubMed ID: 8866334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bradykinin stimulates phosphoinositide turnover and phospholipase C but not phospholipase D and NADPH oxidase in human neutrophils.
    Catz SD; Steŕin-Speziale NB
    J Leukoc Biol; 1996 Apr; 59(4):591-7. PubMed ID: 8613709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PMN superoxide radical production following a metabolic-endocrine simulation of trauma.
    Moon BC; Girotti MJ; Dawson R; Wren SF
    Ann Surg; 1986 Mar; 203(3):246-9. PubMed ID: 3006614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H2-antagonist inhibition of human neutrophil superoxide anion synthesis.
    Zimmerman J; Millard J
    Clin Pharmacol Ther; 1989 May; 45(5):487-94. PubMed ID: 2541961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of the enzyme assay for NADPH oxidoreductase; application to polymorphonuclear leukocyte superoxide anion generation.
    Zimmerman JJ; Shelhamer JH; Parrillo JE
    Crit Care Med; 1985 Mar; 13(3):197-203. PubMed ID: 2982545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a 5-lipoxygenase inhibitor, AA861, on lipoxygenase metabolism and superoxide anion generation by human polymorphonuclear leukocytes--potentiation of superoxide anion generation by LTB4.
    Tanaka K; Abe M; Shigematsu N
    Int Arch Allergy Immunol; 1992; 98(4):361-9. PubMed ID: 1330136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory effects of prostaglandin E1: in vivo modulation of the formyl peptide chemotactic receptor on the rat neutrophil.
    Fantone JC; Marasco WA; Elgas LJ; Ward PA
    J Immunol; 1983 Apr; 130(4):1495-7. PubMed ID: 6300229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of non-steroidal anti-inflammatory drugs on superoxide generation.
    Yuda Y; Tanaka J; Suzuki K; Igarashi K; Satoh T
    Chem Pharm Bull (Tokyo); 1991 Apr; 39(4):1075-7. PubMed ID: 1654219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration-dependent regulatory effects of prostaglandin E1 on human neutrophil function in vitro.
    Farmer JC; Burkey TH; Kew RR; Webster RO
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):593-9. PubMed ID: 1654039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated neutrophils inhibit Na(+)-K(+)-ATPase in canine renal basolateral membrane.
    Julin CM; Zimmerman JJ; Sundaram V; Chobanian MC
    Am J Physiol; 1992 Jun; 262(6 Pt 1):C1364-70. PubMed ID: 1319673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of prostaglandin E1 for prevention of respiratory failure in high risk trauma patients: a prospective clinical trial and correlation with plasma suppressive factors for neutrophil activation.
    Vassar MJ; Fletcher MP; Perry CA; Holcroft JW
    Prostaglandins Leukot Essent Fatty Acids; 1991 Dec; 44(4):223-31. PubMed ID: 1667693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E1 and prostaglandin I2 modulation of superoxide production by human neutrophils.
    Fantone JC; Kinnes DA
    Biochem Biophys Res Commun; 1983 Jun; 113(2):506-12. PubMed ID: 6307290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of prostaglandin E1 on human neutrophil function.
    Mikawa K; Akamatsu H; Maekawa N; Nishina K; Obara H; Niwa Y
    Prostaglandins Leukot Essent Fatty Acids; 1994 Oct; 51(4):287-91. PubMed ID: 7846097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.